Morgan Stanley (MS) Stock Forecast & Price Target

$107.70 -11.57 (-9.70%)

Closing price 04/3/2025 03:59 PM Eastern

Extended Trading

$101.00 -6.70 (-6.22%)

As of 07:53 AM Eastern

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 18 Analyst Ratings

Sell
0

Hold
12

Buy
6

Based on 18 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 12 have given a hold rating, and 6 have given a buy rating for MS.

Consensus Price Target

$129.87
20.58% Upside

According to the 18 analysts' twelve-month price targets for Morgan Stanley, the average price target is $129.87. The highest price target for MS is $156.00, while the lowest price target for MS is $105.00. The average price target represents a forecasted upside of 20.58% from the current price of $107.70.

Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

MS Analyst Ratings Over Time

Type	Current Forecast 4/4/24 to 4/4/25	1 Month Ago 3/5/24 to 3/5/25	3 Months Ago 1/5/24 to 1/4/25	1 Year Ago 4/5/23 to 4/4/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	12 Hold rating(s)	11 Hold rating(s)	11 Hold rating(s)	11 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$129.87	$131.27	$121.80	$95.30
Forecasted Upside	20.58% Upside	6.08% Upside	-3.29% Downside	3.28% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Remove Ads

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Morgan Stanley Stock vs. The Competition

Type	Morgan Stanley	Finance Companies	S&P 500
Consensus Rating Score	2.33	2.53	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	20.58% Upside	55.42% Upside	25.02% Upside
News Sentiment Rating	Positive News See Recent MS News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/3/2025	JPMorgan Chase & Co. 2 of 5 stars	Kian Abouhossein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$129.00 ➝ $125.00	+4.73%
4/2/2025	Bank of America 3 of 5 stars	Michael Carrier Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$150.00 ➝ $144.00	+24.33%
4/1/2025	Evercore ISI 2 of 5 stars	Glenn Schorr Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$150.00 ➝ $138.00	+20.38%
3/28/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$142.00 ➝ $130.00	+11.34%
3/24/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$135.00 ➝ $125.00	+0.67%
3/19/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Ramsden Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$144.00 ➝ $126.00	+6.24%
3/17/2025	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
1/21/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$130.00 ➝ $140.00	+2.81%
1/17/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Goldberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$155.00 ➝ $156.00	+13.27%
1/17/2025	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Konrad Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Market Perform ➝ Market Perform	$138.00 ➝ $145.00	+6.78%
Get the Latest News and Ratings for MS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Morgan Stanley and its competitors with MarketBeat's FREE daily newsletter.
11/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Martinez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$128.00 ➝ $131.00	-2.00%
10/17/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$108.00 ➝ $122.00	+1.66%
10/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$120.00 ➝ $135.00	+12.69%
7/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform
7/18/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$116.00 ➝ $118.00	+10.42%
7/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
4/16/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$97.00 ➝ $108.00	+20.82%
11/28/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$80.00	+2.63%
11/20/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$85.00	+5.88%
10/23/2023	Odeon Capital Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$79.15	+8.72%
10/20/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Peer Perform
8/1/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	-1.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:54 AM ET.

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 31, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

Here are some ways that investors could benefit from investing in Morgan Stanley:

The stock recently traded at $115.23, showing resilience in a fluctuating market, which may indicate a potential for recovery and growth.
Recent earnings results showed an EPS of $2.22, significantly beating analysts' expectations of $1.54, suggesting strong financial performance and effective management.
Institutional investors and hedge funds own 84.19% of Morgan Stanley's stock, indicating strong confidence from large financial entities in the company's future prospects.
Recent unusual options trading activity, with a 35% increase in put options, may suggest that traders are anticipating significant movements in the stock, which could present opportunities for savvy investors.
Allstate Corp's recent investment of $4.52 million in Morgan Stanley reflects growing institutional interest, which can be a positive signal for potential investors.

Morgan Stanley
Bear Case

Investors should be bearish about investing in Morgan Stanley for these reasons:

The stock has experienced a decline of 3.2% recently, which may indicate underlying issues or market volatility that could affect future performance.
High debt-to-equity ratio of 3.14 suggests that Morgan Stanley is heavily leveraged, which can increase financial risk, especially in uncertain economic conditions.
Insider selling activity, including significant sales by the CFO and another insider, may raise concerns about the company's future outlook from those who are most familiar with its operations.
The company's quick and current ratios are both at 0.80, indicating potential liquidity issues, as these ratios are below the ideal benchmark of 1.0, which could affect its ability to meet short-term obligations.
Market fluctuations and economic uncertainties could impact Morgan Stanley's performance, as evidenced by the recent volatility in stock prices and trading volumes.

MS Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $129.87, with a high forecast of $156.00 and a low forecast of $105.00.
: 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 12 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.
: According to analysts, Morgan Stanley's stock has a predicted upside of 20.58% based on their 12-month stock forecasts.
: Over the previous 90 days, Morgan Stanley's stock had 1 downgrade by analysts.
: Morgan Stanley has been rated by research analysts at Bank of America, Barclays, Citigroup, Erste Group Bank, Evercore ISI, JPMorgan Chase & Co., Keefe, Bruyette & Woods, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
: Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.
: Analysts like Morgan Stanley less than other "finance" companies. The consensus rating for Morgan Stanley is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MS) was last updated on 4/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Morgan Stanley (MS) Stock Forecast & Price Target